Aumolertinib (Amelie)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 10:59, 20 September 2022 by Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: Third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). <br>Route: PO <br>Extravasation: n/a ==Dise...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism: Third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI).
Route: PO
Extravasation: n/a

Diseases for which it is used

Also known as

  • Code name: HS-10296
  • Generic name: almonertinib
  • Brand name: Amelie

References

Retrieved from "https://hemonc.org/w/index.php?title=Aumolertinib_(Amelie)&oldid=61993"